Skip to main content

Inbiomotion signs up an ex-manager from Amgen for its board

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

The newspaper Expansión echoes the incorporation of Dr. David L. Lacey to the Administrative Board of the company Inbiomiotion. Set up by Roger Gomis, IRB Barcelona researcher who heads the "Growth control and cancer metastasis” group, Inbiomiotion is devoted to the development of biomarkers for the prediction of bone metastases.

Read news article in Expansión (PDF in Spanish)

Also in La Vanguardia (PDF in Spanish)

Link to news in IRB Barcelona

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).